Philips Healthcare’s Moneshia zu Eltz discusses future of digital health at
OurCrowd’s Global Investor Summit 2016
JOHN SMITH
Highlight The Features
Feature One
Feature Two
Feature Three
Feature Four
What People Are Saying About Voyage
JANE SMITH
A very clear closing argument statement of your offer.
Zu Eltz describes Philips Healthcare’s
Partnership & Collaboration Model
OurCrowd Portfolio Companies shaping the future of digital health
Sight Diagnostics is pioneering an innovative computer vision platform for cheaper, faster, and fully-automated blood diagnostics whose first application is the 300 million annual tests for Malaria worldwide. The Sight Diagnostics platform combines computer vision with patented blood-preparation techniques to count blood cells and differentiate between healthy and parasite-infected blood.
www.sightdx.com
Copyright © 2018 OurCrowd.
Yossi Bahagon, Chairman, Sweetch
Seth Salpeter, Chief Science Officer, Sight Diagnostics
Featured Content
Changing the Landscape of MedTech Investing
Duis fringilla quam a libero convallis, a lacinia metus tempus. Donec vel erat dolor. Quisque sed cursus eros.
READ MORE
Changing the Landscape of MedTech Investing
Duis fringilla quam a libero convallis, a lacinia metus tempus. Donec vel erat dolor. Quisque sed cursus eros.
READ MORE
Changing the Landscape of MedTech Investing
Duis fringilla quam a libero convallis, a lacinia metus tempus. Donec vel erat dolor. Quisque sed cursus eros.
READ MORE
Startups
Since its inception in 2013, OurCrowd and its investor community have made 91 investments totaling $200 million and ~20% of the investments made have been in medical devices, healthcare, and big data for the medical industry.
OurCrowd has more than 75 other companies in its portfolio, in e-commerce, IoT, AutoTech, AgTech, Cybersecurity, VR, Real Estate Tech, Social, and Enterprise Software
As Featured In:
Dr. Morris Laster
OurCrowd Venture Partner
20 yrs of experience in biopharmaceuticals
Founder of 6 companies that have gone public in the US, UK and Israel
S. Morry Blumenfeld
Head of OurCrowd’s Medical Advisory Board
President and CEO of Quescon Consultants Former executive at GE for ~35 years Initiated CT and MRI business at GE Medical Systems.
Norbert Pelc, PhD, Sc.D.
Advisor
Boston Scientific Applied Biomedical Engineering Professor Stanford University Chair Bioengineering
Dr. Ziv Haskal, FSIR FAHA FACR
Advisor
Top Endovascular Specialist and Interventional Radiology expert Professor of Radiology, University of Virginia School of Medicine Editor-in-chief, Journal of Interventional and Vascular Radiology
Reuben Mezrich, PhD, MD, FACR
Advisor
Professor and former chair of the Departmniversity of Maryland School of Medicine
Dr. Zev Davis, M.D.
Advisor
Serves as Director of Cardiovascular Surgery of the Edward Heart Hospital in Naperville, Illinois. Dr. Davis serves as a partner in Cardiac Surgery Associates.
OurCrowd’s investment ecosystem includes a medical Venture Partner and a Medical Advisory Board, who advise, guide, and serve as board members for our MedTech portfolio. OurCrowd’s Medical Advisory Board includes:
OurCrowd's professional team is comprised of entrepreneurs, venture capitalists, investors, and geeks with decades of combined experience building businesses, raising capital, and investing in Israeli and global startups. OurCrowd’s leadership includes:
Pairing OurCrowd's investment efficiency, control, independence and dynamic early stage deal orgination with strategic and prominent venture capital firms, global corporate partners, private equity, angel groups and super-angels.
Corporate, Institutional, and Venture Capital Co-Investors include:
Co-Investors
Israel: The Ideal Ecosystem for MedTech Investing
HIL Applied Medical is developing a new class of ultra-compact, high-performance accelerators for cancer proton therapy. HIL’s patented approach to particle acceleration and beam delivery enables reduction in the size, complexity and cost of a proton therapy system. The unique properties of laser-accelerated proton beams allow for further savings in the ancillary magnetic systems used for beam shaping and delivery, while providing state-of-the-art clinical capabilities.
*OurCrowd invested $1.2 million in HIL Applied Medical in 2014
$200M
TOTAL
RAISED
91
COMPANIES
FUNDED
4,000
COMPANIES
VETTED
11,000
ACCREDITED
INVESTORS
110
COUNTRIES
REPRESENTED
Iron dome missile defense technology that integrates a diverse set of sensors responding with the appropriate action
$14.8M
FUNDED
“Healthcare is personal,” Zu Eltz affirmed as she addressed the audience of thousands of investors, “it’s about… our individual health, the health of friends and family, [and] people that we live with.” Following Zu Eltz’s opening statements, the panel of startups that presented (see below) continued in the light of Philips Healthcare’s universal and impactful investment theme of “the promise of healthcare for all and population health, as well ‘our individual health.”
“With technology we’re at the cusp of the promise of changing healthcare and the way that it’s practiced in the future.” –Monesha Zu Eltz, VP Strategic Alliance and Partnering at Philips
Learn more about how to become part of the MedTech investment landscape, and how to invest in game-changing startups through OurCrowd.
Access pre-vetted startup investment opportunities.
Perform self-guided investment research with curated diligence materials.
Invest alongside trusted venture capital and angel investors.
How do I invest in
Healthcare Startups ?
Hand-picked startup investments
Medical Advisory Board
Core Leadership
Jonathan Medved
Founder and CEO
Jonathan Medved is according to the Washington Post, ”one of Israel’s leading high tech venture capitalists”. In the September, 2008 NY Times Supplement “Israel at 60” Medved was named one of the top 10 most influential Americans who have impacted Israel.
Elan Zivotofsky
Head of Investments
15 years’ experience in Israeli investing as Managing Partner at Prelude Israel, head of technology banking at Lehman Brothers Israel and tech research analyst for Goldman Sachs
Pini Lozowick
General Partner and Chief Investment Officer
Serial entrepreneur, angel investor and venture capitalist, Previously general partner at Alta Berkeley, Director of Marketing at Broadcom, Chairman of Provigent, and founder and GM of Verisense
David Stark
Partner, Investments
Previously investment analyst at Blackstone in Real Estate PE Group
Gadi Mazor
General Partner and CTO
Serial entrepreneur, founding three startups in character and voice recognition and wireless communications
Previously sat on RIM (Blackberry) advisory board, and served on the US Senate committee that defined the US public alert system
Shai Ben Tovim
Partner and Chief Product Officer
Previously Head of Product at Wonga.com, President of R&D and Corp VP of Strategy at Alvarion
Joel Maryles
Venture Partner and Chief Exit Officer
Previously established and managed the Israeli investment banking operations for Citigroup/Salomon Smith Barney and ran it for over a decade, completing 60+ successful transactions including IPOs, private placements, debt offerings and mergers and acquisitions
Janine Kutliroff
Chief Client Officer
Previously founder and CEO of Omek Interactive, acquired by Intel, CEO of IDT Global Israel
Accelerating Investment in Digital Health
Elad Benjamin, CEO Zebra Medical Vision
Yossi Bahagon, Chairman, Sweetch
Sight Diagnostics is pioneering an innovative computer vision platform for cheaper, faster, and fully-automated blood diagnostics whose first application is the 300 million annual tests for Malaria worldwide. The Sight Diagnostics platform combines computer vision with patented blood-preparation techniques to count blood cells and differentiate between healthy and parasite-infected blood.
Philips' Head of Strategic Partnerships discusses working with startups
Since its inception in 2013, OurCrowd and its investor community have made 91 investments totaling $200 million -- and ~20% of the investments made have been in medical devices, healthcare, and big data for the medical industry.
Seth Salpeter, Chief Science Officer, Sight Diagnostics
Accelerating Investment in Digital Health: Philips' Head of Strategic Partnerships discusses working with startups
Predicting and Preventing Diabetes at Scale
Global startups that are building the tech that will power our future
Discover and Invest in Tech Startups
Founder Seeking Capital? Click Here
Innovative technology bringing lung-function testing to the desktop
$1.4M
FUNDED
Hand-picked
Professionally-vetted startups
Co-invest
Today’s biggest returns are going to early investors in private companies, especially high-growth technology companies that are changing nearly every aspect of life. Rather than wait for a company to go public, often at a high price, OurCrowd’s equity crowdfunding platform allows investors exclusive opportunities to buy stakes in private startup companies for as little as $10,000.
The graph below shows how the days of seeing 600% returns in public technology companies are largely over, with such opportunities confined to private investments.
$220M
93
COMPANIES FUNDED
TOTAL RAISED
ACCREDITED INVESTORS
12,000
AS FEATURED IN
*Accredited Investors only
+120
more
OurCrowd invites individual investors from around the world to become part of Israel's legendary innovation. We offer numerous exclusive opportunities to participate in this rapidly expanding high-tech ecosystem.
COMPANIES FUNDED
TOTAL RAISED
ACCREDITED INVESTORS
12,000
110
COUNTRIES REPRESENTED
All of our companies are hand-picked startups, backed by some of the most respected venture-capital firms and angel investors.
$220M
93
4,000
COMPANIES VETTED
Why Startups?
Why Startups?
Early-stage Investment Opportunities
Alongside trusted venture capital and angel investors
Source: Andreesen Horowitz. Recreated from slide 30 of "U.S. Technology funding -- What's Going On?"